Location History:
- Mevasseret Zion, IL (1998)
- Mevasserei Zion, IL (2002 - 2007)
Company Filing History:
Years Active: 1998-2007
Title: Arie Shteyer: Innovator in Osteogenic Peptides
Introduction
Arie Shteyer is a notable inventor based in Mevaseret Zion, IL. He has made significant contributions to the field of synthetic peptides and pseudopeptides, particularly those with osteogenic activity. With a total of 3 patents, his work focuses on enhancing bone cell proliferation and formation.
Latest Patents
Shteyer's latest patents include innovative pharmaceutical compositions that utilize synthetic peptides and pseudopeptides. One of his key inventions is a cyclic to synthetic pseudopeptide derivative of osteogenic growth polypeptide (OGP) and OGP(10-14). This invention is capable of enhancing bone cell proliferation and bone formation. The pharmaceutical compositions he developed are designed to stimulate the formation of osteoblastic or fibroblastic cells, enhance bone formation in osteopenic conditions, repair fractures, heal wounds, and reverse bone loss in osteoporosis.
Career Highlights
Arie Shteyer is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been pivotal in advancing the understanding and application of osteogenic peptides in medical treatments.
Collaborations
Some of his notable coworkers include Itai A Bab and Andras Muhlrad, who have collaborated with him on various projects related to his inventions.
Conclusion
Arie Shteyer's contributions to the field of osteogenic peptides have the potential to significantly impact medical treatments for bone-related conditions. His innovative work continues to pave the way for advancements in pharmaceutical compositions aimed at enhancing bone health.